Literature DB >> 22109984

Optochemical genetics.

Timm Fehrentz1, Matthias Schönberger, Dirk Trauner.   

Abstract

Transmembrane receptors allow a cell to communicate with its environment in response to a variety of input signals. These can be changes in the concentration of ligands (e.g. hormones or neurotransmitters), temperature, pressure (e.g. acoustic waves or touch), transmembrane potential, or light intensity. Many important receptors have now been characterized in atomic detail and our understanding of their functional properties has markedly increased in recent years. As a consequence, these sophisticated molecular machines can be reprogrammed to respond to unnatural input signals. In this Review, we show how voltage-gated and ligand-gated ion channels can be endowed with synthetic photoswitches, and how the resulting artificial photoreceptors can be used to optically control neurons with exceptional temporal and spatial precision. They work well in animals and might find applications in the restoration of vision and the optical control of other sensations. The combination of synthetic photoswitches and receptor proteins contributes to the field of optogenetics and adds a new functional dimension to chemical genetics. As such, we propose to call it "optochemical genetics".
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22109984     DOI: 10.1002/anie.201103236

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  77 in total

1.  Neurochemistry: Lighting up with azobenzenes.

Authors:  G Andrew Woolley
Journal:  Nat Chem       Date:  2012-01-24       Impact factor: 24.427

2.  Optical control of endogenous proteins with a photoswitchable conditional subunit reveals a role for TREK1 in GABA(B) signaling.

Authors:  Guillaume Sandoz; Joshua Levitz; Richard H Kramer; Ehud Y Isacoff
Journal:  Neuron       Date:  2012-06-21       Impact factor: 17.173

3.  Optochemical control of genetically engineered neuronal nicotinic acetylcholine receptors.

Authors:  Ivan Tochitsky; Matthew R Banghart; Alexandre Mourot; Jennifer Z Yao; Benjamin Gaub; Richard H Kramer; Dirk Trauner
Journal:  Nat Chem       Date:  2012-01-10       Impact factor: 24.427

4.  Understanding and improving photo-control of ion channels in nociceptors with azobenzene photo-switches.

Authors:  Alexandre Mourot; Christian Herold; Michael A Kienzler; Richard H Kramer
Journal:  Br J Pharmacol       Date:  2017-07-27       Impact factor: 8.739

5.  Proceedings of the First International Optogenetic Therapies for Vision Symposium.

Authors:  Peter J Francis; Brian Mansfield; Stephen Rose
Journal:  Transl Vis Sci Technol       Date:  2013-11-21       Impact factor: 3.283

6.  Optical control of an ion channel gate.

Authors:  Damien Lemoine; Chloé Habermacher; Adeline Martz; Pierre-François Méry; Nathalie Bouquier; Fanny Diverchy; Antoine Taly; François Rassendren; Alexandre Specht; Thomas Grutter
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

7.  Development of a new photochromic ion channel blocker via azologization of fomocaine.

Authors:  Matthias Schoenberger; Arunas Damijonaitis; Zinan Zhang; Daniel Nagel; Dirk Trauner
Journal:  ACS Chem Neurosci       Date:  2014-06-05       Impact factor: 4.418

8.  A red-shifted, fast-relaxing azobenzene photoswitch for visible light control of an ionotropic glutamate receptor.

Authors:  Michael A Kienzler; Andreas Reiner; Eric Trautman; Stan Yoo; Dirk Trauner; Ehud Y Isacoff
Journal:  J Am Chem Soc       Date:  2013-11-14       Impact factor: 15.419

9.  Heritable expansion of the genetic code in mouse and zebrafish.

Authors:  Yuting Chen; Ji Ma; Wenqing Lu; Meilin Tian; Marion Thauvin; Chonggang Yuan; Michel Volovitch; Qian Wang; Jeff Holst; Mingyao Liu; Sophie Vriz; Shixin Ye; Lei Wang; Dali Li
Journal:  Cell Res       Date:  2016-12-09       Impact factor: 25.617

10.  Current Topics of Optogenetics for Medical Applications Toward Therapy.

Authors:  Toshihiro Kushibiki
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.